Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,067
Closed -$218K 786
2023
Q3
$218K Sell
5,067
-14
-0.3% -$653 ﹤0.01% 687
2023
Q2
$243K Buy
5,081
+13
+0.3% +$627 ﹤0.01% 664
2023
Q1
$247K Sell
5,068
-58
-1% -$2.95K ﹤0.01% 663
2022
Q4
$271K Sell
5,126
-55
-1% -$2.71K ﹤0.01% 617
2022
Q3
$227K Sell
5,181
-509
-9% -$25.1K ﹤0.01% 629
2022
Q2
$285K Buy
5,690
+30
+0.5% +$1.46K ﹤0.01% 566
2022
Q1
$294K Buy
5,660
+220
+4% +$11.4K ﹤0.01% 602
2021
Q4
$321K Buy
5,440
+152
+3% +$8.71K ﹤0.01% 582
2021
Q3
$290K Sell
5,288
-61
-1% -$3.4K ﹤0.01% 591
2021
Q2
$274K Sell
5,349
-261
-5% -$13.5K ﹤0.01% 609
2021
Q1
$290K Buy
5,610
+244
+5% +$13.4K ﹤0.01% 558
2020
Q4
$301K Buy
5,366
+5
+0.1% +$267 ﹤0.01% 454
2020
Q3
$297K Buy
5,361
+136
+3% +$7.05K ﹤0.01% 419
2020
Q2
$237K Buy
+5,225
New +$234K ﹤0.01% 461
2019
Q3
Sell
-5,281
Closed -$227K 584
2019
Q2
$227K Hold
5,281
﹤0.01% 476
2019
Q1
$228K Buy
+5,281
New +$212K ﹤0.01% 462

Other funds holding QGEN

Greenleaf Trust's QGEN Position: Q4 2023 in Review

Greenleaf Trust sold out of Qiagen (QGEN) in Q4 2023, closing a stake of 5,067 shares — an estimated $218K sold.

Greenleaf Trust first reported a position in QGEN in Q1 2019 and held it in 16 quarters. The position peaked at $321K in Q4 2021. 277 funds tracked by Wall St. Rank hold QGEN as of Q4 2023.

  • Greenleaf Trust reported no remaining Qiagen position as of Q4 2023 after selling out during the quarter.
  • Greenleaf Trust sold 5,067 Qiagen shares in Q4 2023, an estimated $218K.
  • Greenleaf Trust first reported a position in Qiagen in Q1 2019 and held it in 16 quarters.
  • Greenleaf Trust's Qiagen position peaked at $321K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Qiagen as of Q4 2023.

Based on Greenleaf Trust's 13F filing for Q4 2023, filed 31 Jan 2024.